Role of shalmali moola tablets to Increase sperm count

AN OPEN LABEL RANDOMIZED STANDARD CONTROLLED CLINICAL TRIAL ON THE EFFECT OF SHALMALI MOOLA (Shalmalia Malabarica. L) TABLET IN OLIGOSPERMIA (KSHEENA SHUKRA) - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/071016

Enrollment

100

Registered

2024-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: N461- Oligospermia Health Condition 3: N461- Oligospermia

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of oligospermia Sperm count less than 15 million/ml.

Exclusion criteria

Exclusion criteria: Patients with azoospermia & aspermia, Teratospermia more than14% 2. Patient with known sexually transmitted disease. 3. Sperm count greater than 15 million/ml. 4. Systemic diseases like known case of diabetes mellitus will be excluded from the study. 5. Semen samples showing high viscosity and low liquefaction time.

Design outcomes

Primary

Measure	Time frame
To Analyze the Effect of Shalmali moola tablets on Sperm Count.Timepoint: 30 days	—

Secondary

Measure	Time frame
To Evaluate the Effect of Shalmali moola Tablets on LDL, LH & S.Testosterone.Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Yogesh S Deole

CVM UNIVERSITY

yogesh.deole@cvmu.edu.in997499309

Outcome results